Authors: MULS E VANGANSE E CLOSON MC

Citation: E. Muls et al., COST-EFFECTIVENESS OF PRAVASTATIN IN SECONDARY PREVENTION OF CORONARYHEART-DISEASE - COMPARISON BETWEEN BELGIUM AND THE UNITED-STATES OF APROJECTED RISK MODEL, Atherosclerosis (Amsterdam), 137, 1998, pp. 111-116

Authors: GREGOIRE V HAMOIR M BUSSELS J CLOSON MC EECKHOUDT L COUNOY H ROSIER JF SCALLIET P

Citation: V. Gregoire et al., COST MINIMIZATION ANALYSIS OF TREATMENT OF T1N0 GLOTTIC SQUAMOUS-CELLCARCINOMAS - COMPARISON BETWEEN RADIOTHERAPY, LASER MICROSURGERY AND PARTIAL LARYNGECTOMY, European journal of cancer, 33, 1997, pp. 27-27

Authors: MULS E VANGANSE E CLOSON MC

Citation: E. Muls et al., ECONOMIC-ANALYSIS OF LIPID-LOWERING COST IN BELGIUM, Atherosclerosis, 130, 1997, pp. 153-153

Authors: CLOSON MC CROTT R EVENADIN D

Citation: Mc. Closon et al., DRUG-USE IN RELATION TO CLINICAL ACTIVITIES AS AN INSTRUMENT FOR PROSPECTIVE DRUG BUDGETING - THE BELGIAN EXPERIENCE, PharmacoEconomics, 9(3), 1996, pp. 246-263